A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
To the Editor: An epidemic of coronavirus SARS-CoV-2 has become the focus of scientific
attention. 1 The high infectivity of SARS-CoV-2 and rapid rise in the number of patients …
attention. 1 The high infectivity of SARS-CoV-2 and rapid rise in the number of patients …
[HTML][HTML] Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
E Mira, OA Yarce, C Ortega, S Fernández… - The Journal of Allergy …, 2020 - ncbi.nlm.nih.gov
A patient with X-linked agammaglobulinemia was infected with severe acute respiratory
syndrome coronavirus 2 and presented a 40-day long and stagnant clinical evolution …
syndrome coronavirus 2 and presented a 40-day long and stagnant clinical evolution …
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
The coronavirus disease 2019 (COVID-19) pandemic has presented a global challenge.
The pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
The pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City
The clinical impact of coronavirus disease 2019 in primary immunodeficiency diseases
varies from mild illness to death. In our center, humoral immunodeficiency patients with poor …
varies from mild illness to death. In our center, humoral immunodeficiency patients with poor …
[HTML][HTML] Severe COVID-19 in patients with B cell alymphocytosis and response to convalescent plasma therapy
Discussion We describe two cases of severe COVID-19 with ARDS in patients with
hypogammaglobulinemia and B cell alymphocytosis. One patient died despite mechanical …
hypogammaglobulinemia and B cell alymphocytosis. One patient died despite mechanical …
[HTML][HTML] COVID-19 infection in 10 common variable immunodeficiency patients in New York City
B Cohen, R Rubinstein, MD Gans, L Deng… - The Journal of Allergy …, 2021 - ncbi.nlm.nih.gov
Common variable immunodeficiency (CVID), the most prevalent humoral immunodeficiency,
is characterized by hypogammaglobulinemia, impaired vaccine responses, and recurrent …
is characterized by hypogammaglobulinemia, impaired vaccine responses, and recurrent …
Successful use of methylprednisolone for treating severe COVID-19
J Liu, X Zheng, Y Huang, H Shan… - Journal of Allergy and …, 2020 - jacionline.org
To the Editor: As of April 4, 2020, a total of 1,051,635 coronavirus disease 2019 (COVID-19)
cases had been reported worldwide, among which 56,985 deaths occurred (5.42%). 1 …
cases had been reported worldwide, among which 56,985 deaths occurred (5.42%). 1 …
Does asthma affect morbidity or severity of COVID-19?
K Matsumoto, H Saito - Journal of Allergy and Clinical Immunology, 2020 - jacionline.org
Coronavirus disease 2019 (COVID-19) has afflicted at least 4.9 million patients worldwide,
causing more than 328,000 deaths to date. This pandemic impacts not only social and …
causing more than 328,000 deaths to date. This pandemic impacts not only social and …
[HTML][HTML] Asthma prolongs intubation in COVID-19
M Mahdavinia, KJ Foster, E Jauregui… - The journal of allergy …, 2020 - ncbi.nlm.nih.gov
Asthma was independently associated with prolonged duration of intubation for coronavirus
disease 2019. The co-occurrence of asthma with obesity, another predictor of poor outcome …
disease 2019. The co-occurrence of asthma with obesity, another predictor of poor outcome …
[HTML][HTML] Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor?
The novel coronavirus disease 19 (COVID-19) is an acute infectious respiratory disorder that
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …
emerged from Wuhan, China in the late 2019. 1, 2 Due to its rapid distribution, the disease …